Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Equity (Parenthetical)

v3.24.3
Consolidated Statements of Equity (Parenthetical) - shares
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Statement of Stockholders' Equity [Abstract]        
Beginning balance (in shares) 112,650,930 112,538,555 112,555,352 112,423,893
Conversion of common units to common shares (in shares) 40,000   40,000  
Share-based compensation issued, net of redemptions (in shares) 2,276 9,291 97,854 123,953
Ending balance (in shares) 112,693,206 112,547,846 112,693,206 112,547,846